Concepedia

Mariko Kajikawa

MK

26

Publications

2.2K

Citations

19

H-Index

1996

Active since

Affiliations

Bayer (Japan)(Current)

Kyoto University

Osaka National Hospital

Jichi Medical University

Tokai University

Mariko Kajikawa is an author at Bayer (Japan) specializing in medicine, cardiovascular disease, and thrombosis.

Top concepts

Publications per year

1996–2017

26

Publications

26

Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation

Masatsugu Hori, Masayasu Matsumoto, Norio Tanahashi et al. · Circulation Journal · 2012 · 631 citations · Full text

Glucose intolerance caused by a defect in the entero-insular axis: A study in gastric inhibitory polypeptide receptor knockout mice

Kazumasa Miyawaki, Yuichiro Yamada, Hideki Yano et al. · Proceedings of the National Academy of Sciences · 1999 · 453 citations

, , +17

An Insulinotropic Effect of Vitamin D Analog with Increasing Intracellular Ca2+ Concentration in Pancreatic β-Cells through Nongenomic Signal Transduction1

Mariko Kajikawa, Hitoshi Ishida, Shimpei Fujimoto et al. · Endocrinology · 1999 · 109 citations · Full text

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program

Norikazu Yamada, Atsushi Hirayama, Hideaki Maeda et al. · Thrombosis Journal · 2015 · 109 citations · Full text

Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation

Takahiko Tanigawa, Masato Kaneko, Kensei Hashizume et al. · Drug Metabolism and Pharmacokinetics · 2012 · 102 citations

Rows per page

1–5 of 26